PALBOCIB-125 (Palbociclib 125mg) x 21 CAPSULES.
Generic name: Palbociclib.
Brand name: Aprazer.
Class: Cyclin-Dependent Kinase (CDK) 4/6 Inhibitors.
Pack size: 21 capsules.
Form: Capsules.
Strength: 125 mg.
Amount: ₦‎270,000

Description: Palbocib-125 (Palbociclib, 125mg) capsules are used to treat hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer. It is typically used in combination with other cancer treatments, such as an aromatase inhibitor or fulvestrant, to slow down the growth of cancer cells by inhibiting CDK4 and CDK6 enzymes.

Key features:
• Specifically targets and inhibits CDK4 and CDK6 enzymes to slow cancer cell growth.
• Often used with other treatments for enhanced effectiveness.
• Comes in an easy-to-take 125mg capsules.

Side Effects:
• Common side effects include neutropenia, fatigue, nausea, diarrhoea, and stomatitis. Serious side effects may involve infections and liver dysfunction.

Caution:
• Not recommended during pregnancy or breastfeeding.
• Monitor blood counts regularly and use caution in patients with liver impairment or those taking medications affecting liver enzymes.